Similar to healthy phagocytes, activation of VSTM1 inhibits FcR‐induced ROS production and NET formation in phagocytes of SLE and RA patients in vitro [16, 35, 36, 37, 48]. This evidence concerns the gene VSTM1 and systemic lupus erythematosus.